These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 35130302)
1. Increased mitochondrial proline metabolism sustains proliferation and survival of colorectal cancer cells. Alaqbi SS; Burke L; Guterman I; Green C; West K; Palacios-Gallego R; Cai H; Alexandrou C; Myint NNM; Parrott E; Howells LM; Higgins JA; Jones DJL; Singh R; Britton RG; Tufarelli C; Thomas A; Rufini A PLoS One; 2022; 17(2):e0262364. PubMed ID: 35130302 [TBL] [Abstract][Full Text] [Related]
2. Deciphering the Effects of the PYCR Family on Cell Function, Prognostic Value, Immune Infiltration in ccRCC and Pan-Cancer. Chen H; Chen Q; Chen J; Mao Y; Duan L; Ye D; Cheng W; Chen J; Gao X; Lin R; Lin W; Zhang M; Qi Y Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125668 [TBL] [Abstract][Full Text] [Related]
3. Screening a knowledge-based library of low molecular weight compounds against the proline biosynthetic enzyme 1-pyrroline-5-carboxylate 1 (PYCR1). Meeks KR; Bogner AN; Tanner JJ Protein Sci; 2024 Jul; 33(7):e5072. PubMed ID: 39133178 [TBL] [Abstract][Full Text] [Related]
4. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers. Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297 [TBL] [Abstract][Full Text] [Related]
6. Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target. Bogner AN; Stiers KM; Tanner JJ Amino Acids; 2021 Dec; 53(12):1817-1834. PubMed ID: 34003320 [TBL] [Abstract][Full Text] [Related]
7. Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis. Choi UY; Lee JJ; Park A; Zhu W; Lee HR; Choi YJ; Yoo JS; Yu C; Feng P; Gao SJ; Chen S; Eoh H; Jung JU Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8083-8093. PubMed ID: 32213586 [TBL] [Abstract][Full Text] [Related]
8. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis. Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117 [TBL] [Abstract][Full Text] [Related]
9. Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells. Park JM; Su YH; Fan CS; Chen HH; Qiu YK; Chen LL; Chen HA; Ramasamy TS; Chang JS; Huang SY; Chang WW; Lee AY; Huang TS; Kuo CC; Chiu CF Exp Mol Med; 2024 Sep; 56(9):2065-2081. PubMed ID: 39294443 [TBL] [Abstract][Full Text] [Related]
10. PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets. Shao Z; Lu L; Cui Y; Deng L; Xu Q; Liang Q; Lu X; Zhang J; Chen J; Situ Y Front Biosci (Landmark Ed); 2022 Dec; 27(12):336. PubMed ID: 36624948 [TBL] [Abstract][Full Text] [Related]
11. Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions. Westbrook RL; Bridges E; Roberts J; Escribano-Gonzalez C; Eales KL; Vettore LA; Walker PD; Vera-Siguenza E; Rana H; Cuozzo F; Eskla KL; Vellama H; Shaaban A; Nixon C; Luuk H; Lavery GG; Hodson DJ; Harris AL; Tennant DA Cell Rep; 2022 Feb; 38(5):110320. PubMed ID: 35108535 [TBL] [Abstract][Full Text] [Related]
12. PYCR, a key enzyme in proline metabolism, functions in tumorigenesis. Li Y; Bie J; Song C; Liu M; Luo J Amino Acids; 2021 Dec; 53(12):1841-1850. PubMed ID: 34273023 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox Homeostasis. Hollinshead KER; Munford H; Eales KL; Bardella C; Li C; Escribano-Gonzalez C; Thakker A; Nonnenmacher Y; Kluckova K; Jeeves M; Murren R; Cuozzo F; Ye D; Laurenti G; Zhu W; Hiller K; Hodson DJ; Hua W; Tomlinson IP; Ludwig C; Mao Y; Tennant DA Cell Rep; 2018 Mar; 22(12):3107-3114. PubMed ID: 29562167 [TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of Pycr1 and Pycr2 in mice. Stum MG; Tadenev ALD; Seburn KL; Miers KE; Poon PP; McMaster CR; Robinson C; Kane C; Silva KA; Cliften PF; Sundberg JP; Reinholdt LG; John SWM; Burgess RW Genetics; 2021 May; 218(1):. PubMed ID: 33734376 [TBL] [Abstract][Full Text] [Related]
16. Functional specialization in proline biosynthesis of melanoma. De Ingeniis J; Ratnikov B; Richardson AD; Scott DA; Aza-Blanc P; De SK; Kazanov M; Pellecchia M; Ronai Z; Osterman AL; Smith JW PLoS One; 2012; 7(9):e45190. PubMed ID: 23024808 [TBL] [Abstract][Full Text] [Related]
18. SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism. Chen S; Yang X; Yu M; Wang Z; Liu B; Liu M; Liu L; Ren M; Qi H; Zou J; Vucenik I; Zhu WG; Luo J Neoplasia; 2019 Jul; 21(7):665-675. PubMed ID: 31108370 [TBL] [Abstract][Full Text] [Related]
19. Kindlin-2 links mechano-environment to proline synthesis and tumor growth. Guo L; Cui C; Zhang K; Wang J; Wang Y; Lu Y; Chen K; Yuan J; Xiao G; Tang B; Sun Y; Wu C Nat Commun; 2019 Feb; 10(1):845. PubMed ID: 30783087 [TBL] [Abstract][Full Text] [Related]
20. Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis. Oudaert I; Satilmis H; Vlummens P; De Brouwer W; Maes A; Hose D; De Bruyne E; Ghesquière B; Vanderkerken K; De Veirman K; Menu E J Exp Clin Cancer Res; 2022 Feb; 41(1):45. PubMed ID: 35105345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]